Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

Slide: 24 of 35

Comparative Effectiveness of FGAs and SGAs for Treating Schizophrenia: Response and Remission Rates

Few statistically significant differences in other outcomes (e.g., response and remission rates, utilization of the health care system) were found.

When compared with haloperidol, risperidone yields better relapse rates and olanzapine provides better response and relapse rates in patients with schizophrenia. The strength of evidence for this finding was not rated.